A Message from Consumer Action

Consumer Action's MoneyWi$e educational materials have moved to our Managing Money Project website. Here you may view, download and order bulk copies of the MoneyWi$e materials. Please make a note of the Managing Money Project address— www.managing-money.org —and add it to your address book.

Gilead’s $2,340 price for coronavirus drug draws criticism

Source: Marilynn Marchione, Associated Press

The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. 

The price was swiftly criticized; one consumer group called it “an outrage” because of the amount taxpayers invested toward the drug’s development.

Read Full Article: Gilead’s $2,340 price for coronavirus drug draws criticism

 

Quick Menu

Support Consumer Action

Support Consumer

Join Our Email List

Optional Member Code
Facebook FTwitter T

MoneyWise Modules

Managing Money Topics

Help Desk

Advocacy